Arie Belldegrun Allogene Therapeutics, Inc. (ALLO) insider trading activity
Arie Belldegrun is Director of Allogene Therapeutics, Inc.. Currently has a direct ownership of 1.87 Million shares of ALLO, which is worth approximately $5.6 Million. The most recent transaction as insider was on Jan 25, 2024, when has been sold 211,973 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.87M
0%
3M change
12.81%
12M change
Total Value Held
$5.6 Million
Arie Belldegrun Transaction History
Also insider at
AB
Arie Belldegrun
Director
Princeton, NJ